Literature DB >> 35348995

Hearing screening and amplifier uptake results in a multidisciplinary head and neck cancer survivorship clinic.

Lori Zitelli1,2, Catherine Palmer3,4, Elizabeth Mamula3, Jonas Johnson3,4, Grant Rauterkus5, Marci L Nilsen3,4.   

Abstract

PURPOSE: Hearing loss and tinnitus are prevalent among survivors of head and neck cancer (HNC), but auditory issues are under-addressed in the survivorship literature. The purpose of this study was to describe the hearing loss and management experience of a group of survivors provided with a hearing screening and amplifier assistance if needed during their visit.
METHODS: A retrospective chart review of 1176 individuals seen in the HNC Survivorship Clinic between December 2016 and October 2020 who interacted with audiology was performed.
RESULTS: Of these survivors, 72% failed the 30-dB HL hearing screening at one or more frequencies. Thirty-three percent of the sample reported tinnitus. Consistent with the general population, this group has a low prevalence of hearing aid use. In this clinic, individuals who fail the hearing screening at all frequencies are offered a simple, non-custom amplifier for use during their visit. Thirty-one percent of individuals offered the amplifier used it during their Survivorship Clinic visit to enhance communication and reduce listening effort. Only 54% of individuals who failed the hearing screening self-reported hearing loss. The poor sensitivity and specificity associated with the self-perception of hearing loss data support the need for hearing screening that consists of responding to tones. Of individuals who received a recommendation for a comprehensive hearing test, 21% received a hearing test with 68% of these individuals receiving the hearing test the same day of their Survivorship Clinic visit.
CONCLUSIONS: The data from 1176 survivors of HNC seen by audiology over the past few years as part of the UPMC HNC Survivorship Clinic support the need for hearing management in this population to improve communication during and after the Survivorship Clinic visit. IMPLICATIONS FOR CANCER SURVIVORS: Survivors of HNC have a high prevalence of greater than mild hearing loss and tinnitus (both issues known to negatively impact health-related communication and quality of life). This manuscript describes a hearing screening program within a Survivorship Clinic that identifies individuals in need of non-custom amplification during their appointment to support effective communication. Survivors should be referred to audiologists for evaluation and management of treatment-related issues of hearing.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Head and neck cancer; Hearing Screening; Interventional audiology; Ototoxicity; Survivorship

Year:  2022        PMID: 35348995     DOI: 10.1007/s11764-022-01198-9

Source DB:  PubMed          Journal:  J Cancer Surviv        ISSN: 1932-2259            Impact factor:   4.442


  21 in total

1.  Comprehensive Audiometric Analysis of Hearing Impairment and Tinnitus After Cisplatin-Based Chemotherapy in Survivors of Adult-Onset Cancer.

Authors:  Robert D Frisina; Heather E Wheeler; Sophie D Fossa; Sarah L Kerns; Chunkit Fung; Howard D Sesso; Patrick O Monahan; Darren R Feldman; Robert Hamilton; David J Vaughn; Clair J Beard; Amy Budnick; Eileen M Johnson; Shirin Ardeshir-Rouhani-Fard; Lawrence H Einhorn; Steven E Lipshultz; M Eileen Dolan; Lois B Travis
Journal:  J Clin Oncol       Date:  2016-06-27       Impact factor: 44.544

2.  Communication and Healthcare: Self-Reports of People with Hearing Loss in Primary Care Settings.

Authors:  Madelyn N Stevens; Judy R Dubno; Margaret I Wallhagen; Debara L Tucci
Journal:  Clin Gerontol       Date:  2018-04-27       Impact factor: 2.619

3.  Hearing Impairment and the Amelioration of Avoidable Medical Error: A Cross-Sectional Survey.

Authors:  Patrick Henn; Colm O'Tuathaigh; Darrelle Keegan; Simon Smith
Journal:  J Patient Saf       Date:  2021-04-01       Impact factor: 2.844

4.  Age-Related Hearing Loss and Communication Breakdown in the Clinical Setting.

Authors:  Vikki Cudmore; Patrick Henn; Colm M P O'Tuathaigh; Simon Smith
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2017-10-01       Impact factor: 6.223

5.  Hearing Difficulty Is Associated With Injuries Requiring Medical Care.

Authors:  Paul Mick; Danielle Foley; Frank Lin; M Kathleen Pichora-Fuller
Journal:  Ear Hear       Date:  2018 Jul/Aug       Impact factor: 3.570

Review 6.  Chemoradiation-induced hearing loss remains a major concern for head and neck cancer patients.

Authors:  Nicole C Schmitt; Brandi R Page
Journal:  Int J Audiol       Date:  2017-07-20       Impact factor: 2.117

7.  Burden of treatment: Reported outcomes in a head and neck cancer survivorship clinic.

Authors:  Marci Lee Nilsen; Leila J Mady; Jacob Hodges; Tamara Wasserman-Wincko; Jonas T Johnson
Journal:  Laryngoscope       Date:  2019-01-15       Impact factor: 3.325

8.  Ototoxicity of low- and moderate-dose cisplatin.

Authors:  S D Schaefer; J D Post; L G Close; C G Wright
Journal:  Cancer       Date:  1985-10-15       Impact factor: 6.860

9.  Long-term hearing loss after chemoradiation in patients with head and neck cancer.

Authors:  Eleonoor A R Theunissen; Charlotte L Zuur; Sophie C J Bosma; Marta Lopez-Yurda; Michael Hauptmann; Sieberen van der Baan; Jan Paul de Boer; Lisette van der Molen; Coen R N Rasch; Wouter A Dreschler; Alfons J M Balm
Journal:  Laryngoscope       Date:  2014-06-26       Impact factor: 3.325

Review 10.  Characteristics of radiation-induced sensorineural hearing loss in head and neck cancer: a systematic review.

Authors:  Mario Mujica-Mota; Sofia Waissbluth; Sam J Daniel
Journal:  Head Neck       Date:  2012-12-22       Impact factor: 3.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.